In fragment-based drug discovery, the precision of biophysical tools becomes paramount to deal with extremely small chemical entities. Regardless of your position in the discovery journey, 2bind’s specialized services ensure the delivery of essential insights for informed decision-making. From navigating molecules with weak affinities to handling rapid kinetics, our expertise empowers you to make the right choices at every step.
Team assembly
Protein target analysis (literature research, structural analysis, a priori data analysis, etc.)
Screening library selection:
Selection of technologies and assay cascade definition
Material access and sourcing
Protein target qualification
Screenung assay technical parameter establishment
Positive control establishment
Assay and protein target robustness testing
Assay screening qualification
True biophysical high-throughput screening
Screening with TRIC (MST), Spectral Shift, GCI, nanoDSF TSA
Library screening
Selected library subsets for focused screening
Competition and allosteric binding screenings
Protein-protein interaction (PPI) displacement screening
Screening of protein-macromolecule complexes (e.g. protein-RNA, protein-DNA)
Binding affinity via TRIC (MST), Spectral Shift, ITC
Binding kinetics via GCI
Label-free binding analysis via nanoDSF TSA
Thermodynamic profiling analysis via ITC
Comprehensive in-solution direct binding with TRIC (MST) and Spectral Shift
Comprehensive in-solution, label-free direct binding with ITC
In-solution, label-free nanoDSF TSA
Comprehensive label-free kinetics binding with GCI
Ligand structural effect assays with SEC MALS and DLS
Target-aggregator assays with DLS
Streamlining of suitable hit characterization assay
Regular application of streamlined assay in fragment evolution MedChem cycles
SAR support
What 2bind delivers